View of BASELINE CLINICAL, ECHOCARDIOGRAPHIC, AND BIOMARKER PREDICTORS OF EARLY NT-PROBNP AND GALECTIN-3 DETERIORATION DURING ANTHRACYCLINE CHEMOTHERAPY: A PLACEBO-ARM SECONDARY ANALYSIS

Return to Article Details BASELINE CLINICAL, ECHOCARDIOGRAPHIC, AND BIOMARKER PREDICTORS OF EARLY NT-PROBNP AND GALECTIN-3 DETERIORATION DURING ANTHRACYCLINE CHEMOTHERAPY: A PLACEBO-ARM SECONDARY ANALYSIS Download Download PDF